Articles with public access mandates - Davide ChiasseriniLearn more
Not available anywhere: 12
Review
Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset
D Chiasserini, JRT van Weering, SR Piersma, TV Pham, A Malekzadeh, ...
Journal of proteomics 106, 191-204, 2014
Mandates: European Commission
Review
Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: a systematic review and meta‐analysis
P Eusebi, D Giannandrea, L Biscetti, I Abraha, D Chiasserini, M Orso, ...
Movement disorders 32 (10), 1389-1400, 2017
Mandates: Government of Italy
Review
Lysosomal dysfunction and α‐Synuclein aggregation in Parkinson's disease: diagnostic links
T Moors, S Paciotti, D Chiasserini, P Calabresi, L Parnetti, T Beccari, ...
Movement Disorders 31 (6), 791-801, 2016
Mandates: Netherlands Organisation for Health Research and Development, Government of …
Review
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
V Durante, A de Iure, V Loffredo, N Vaikath, M De Risi, S Paciotti, ...
Brain 142 (5), 1365-1385, 2019
Mandates: Fondazione Cariplo, Government of Italy
Review
Glucocerebrosidase in Parkinson's disease: insights into pathogenesis and prospects for treatment
AHV Schapira, D Chiasserini, T Beccari, L Parnetti
Movement Disorders 31 (6), 830-835, 2016
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Review
Italian consensus recommendations for a biomarker‐based aetiological diagnosis in mild cognitive impairment patients
M Boccardi, V Nicolosi, C Festari, A Bianchetti, S Cappa, D Chiasserini, ...
European journal of neurology 27 (3), 475-483, 2020
Mandates: Government of Italy
Review
Performance evaluation of an automated ELISA system for Alzheimer’s disease detection in clinical routine
D Chiasserini, L Biscetti, L Farotti, P Eusebi, N Salvadori, V Lisetti, ...
Journal of Alzheimer's Disease 54 (1), 55-67, 2016
Mandates: Government of Italy
Review
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
N Kruse, S Persson, D Alcolea, JMC Bahl, I Baldeiras, E Capello, ...
Neurobiology of aging 36 (9), 2587-2596, 2015
Mandates: Danish Council for Strategic Research, Fundação para a Ciência e a …
Review
The clinical use of cerebrospinal fluid biomarkers for Alzheimer’s disease diagnosis: the Italian selfie
GM Sancesario, S Toniolo, D Chiasserini, SG Di Santo, J Zegeer, ...
Journal of Alzheimer's Disease 55 (4), 1659-1666, 2017
Mandates: Government of Italy
Review
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence
M Di Filippo, A Tozzi, M Tantucci, S Arcangeli, D Chiasserini, V Ghiglieri, ...
Neurobiology of Disease 62, 387-393, 2014
Mandates: European Commission, Government of Italy
Review
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases
L Barba, G Bellomo, P Oeckl, D Chiasserini, L Gaetani, EG Torrigiani, ...
Journal of the Neurological Sciences, 123059, 2024
Mandates: Michael J Fox Foundation
Review
P1‐238: ITALIAN CONSENSUS RECOMMENDATIONS FOR THE ETIOLOGICAL DIAGNOSIS IN MEMORY CLINICS
M Boccardi, V Nicolosi, C Festari, A Bianchetti, SF Cappa, D Chiasserini, ...
Alzheimer's & Dementia 15, P328-P329, 2019
Mandates: Government of Italy
Available somewhere: 43
Review
A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ...
Frontiers in neurology 6, 179, 2015
Mandates: Research Foundation (Flanders), Swedish Research Council, Netherlands …
Review
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
Mandates: US National Institutes of Health
Review
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
Mandates: US National Institutes of Health
Review
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
D Chiasserini, S Paciotti, P Eusebi, E Persichetti, A Tasegian, ...
Molecular neurodegeneration 10, 1-6, 2015
Mandates: Alzheimers's UK, UK Medical Research Council, National Institute for Health …
Review
Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in Parkinson's disease patients
L Parnetti, S Paciotti, P Eusebi, A Dardis, S Zampieri, D Chiasserini, ...
Movement Disorders 32 (10), 1423-1431, 2017
Mandates: US National Institutes of Health
Review
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
D Chiasserini, L Biscetti, P Eusebi, N Salvadori, G Frattini, S Simoni, ...
Alzheimer's research & therapy 9, 1-12, 2017
Mandates: Research Foundation (Flanders), Federal Ministry of Education and Research …
Review
Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis
M Di Filippo, A de Iure, C Giampà, D Chiasserini, A Tozzi, PL Orvietani, ...
Scientific reports 6 (1), 20926, 2016
Mandates: European Commission, Government of Italy
Review
Proteomic biomarkers for the detection of endometrial cancer
K Njoku, D Chiasserini, AD Whetton, EJ Crosbie
Cancers 11 (10), 1572, 2019
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Publication and funding information is determined automatically by a computer program